Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Barlocco

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|April 2, 2004
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptorAmedeo Leonardi, Daniela Barlocco, Federica Montesano, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Isolation and pharmacological activities of the Tecoma stans alkaloidsLuca Costantino, Laura Raimondi, Renato Pirisino, et al.
Journal of Medicinal Chemistry|September 29, 2006
Antibacterial agent discovery using thymidylate synthase biolibrary screeningM Paola Costi, Arianna Gelain, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry|June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agentsLaurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry|March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory propertiesFederica Porta, Giorgio Facchetti, Nicola Ferri, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Journal of Medicinal Chemistry|June 26, 2007
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptorsWilliam H Bunnelle, Jerome F Daanen, Keith B Ryther, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Medicinal Chemistry|April 2, 2004
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptorAmedeo Leonardi, Daniela Barlocco, Federica Montesano, et al.
Farmaco (Societa Chimica Italiana : 1989)|September 19, 2003
Isolation and pharmacological activities of the Tecoma stans alkaloidsLuca Costantino, Laura Raimondi, Renato Pirisino, et al.
Journal of Medicinal Chemistry|September 29, 2006
Antibacterial agent discovery using thymidylate synthase biolibrary screeningM Paola Costi, Arianna Gelain, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry|June 26, 2018
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agentsLaurent R Chiarelli, Matteo Mori, Daniela Barlocco, et al.
European Journal of Medicinal Chemistry|March 22, 2017
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory propertiesFederica Porta, Giorgio Facchetti, Nicola Ferri, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 21, 2019
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agentsLaurent R Chiarelli, Matteo Mori, Giangiacomo Beretta, et al.
Journal of Medicinal Chemistry|June 26, 2007
Structure-activity studies and analgesic efficacy of N-(3-pyridinyl)-bridged bicyclic diamines, exceptionally potent agonists at nicotinic acetylcholine receptorsWilliam H Bunnelle, Jerome F Daanen, Keith B Ryther, et al.
Pageof 4